BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 32945431)

  • 21. Oncogenic role of abnormal spindle‑like microcephaly‑associated protein in lung adenocarcinoma.
    Wang J; Liang J; Li H; Han J; Jiang J; Li Y; Feng Z; Zhao R; Tian H
    Int J Oncol; 2021 May; 58(5):. PubMed ID: 33786609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of protein arginine methyltransferase 6 activates interferon signaling and induces the apoptosis of endometrial cancer cells via histone modification.
    Inoue F; Sone K; Kumegawa K; Hachijo R; Suzuki E; Tanimoto S; Tsuboyama N; Kato K; Toyohara Y; Takahashi Y; Kusakabe M; Kukita A; Honjoh H; Nishijima A; Taguchi A; Miyamoto Y; Tanikawa M; Iriyama T; Mori M; Wada-Hiraike O; Oda K; Suzuki H; Maruyama R; Osuga Y
    Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38299254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Arginine Methyltransferase PRMT6 Regulates DNA Methylation and Contributes to Global DNA Hypomethylation in Cancer.
    Veland N; Hardikar S; Zhong Y; Gayatri S; Dan J; Strahl BD; Rothbart SB; Bedford MT; Chen T
    Cell Rep; 2017 Dec; 21(12):3390-3397. PubMed ID: 29262320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protumor Effects of Histone H3-H4 Chaperone Antisilencing Feature 1B Gene on Lung Adenocarcinoma: In Silico and
    Wu L; Jie B
    Comput Math Methods Med; 2021; 2021():5005459. PubMed ID: 34956399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The arginine methyltransferase PRMT6 regulates cell proliferation and senescence through transcriptional repression of tumor suppressor genes.
    Stein C; Riedl S; Rüthnick D; Nötzold RR; Bauer UM
    Nucleic Acids Res; 2012 Oct; 40(19):9522-33. PubMed ID: 22904088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. USF1-induced overexpression of long noncoding RNA WDFY3-AS2 promotes lung adenocarcinoma progression via targeting miR-491-5p/ZNF703 axis.
    Ren P; Hong X; Chang L; Xing L; Zhang H
    Mol Carcinog; 2020 Aug; 59(8):875-885. PubMed ID: 32275336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
    Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PRMT6 Regulates RAS/RAF Binding and MEK/ERK-Mediated Cancer Stemness Activities in Hepatocellular Carcinoma through CRAF Methylation.
    Chan LH; Zhou L; Ng KY; Wong TL; Lee TK; Sharma R; Loong JH; Ching YP; Yuan YF; Xie D; Lo CM; Man K; Artegiani B; Clevers H; Yan HH; Leung SY; Richard S; Guan XY; Huen MSY; Ma S
    Cell Rep; 2018 Oct; 25(3):690-701.e8. PubMed ID: 30332648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NPM3 as an Unfavorable Prognostic Biomarker Involved in Oncogenic Pathways of Lung Adenocarcinoma
    Chen L; Yang D; Huang F; Xu W; Luo X; Mei L; He Y
    Comb Chem High Throughput Screen; 2024; 27(2):203-213. PubMed ID: 37114782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MTHFD2 promotes tumorigenesis and metastasis in lung adenocarcinoma by regulating AKT/GSK-3β/β-catenin signalling.
    Shi Y; Xu Y; Yao J; Yan C; Su H; Zhang X; Chen E; Ying K
    J Cell Mol Med; 2021 Jul; 25(14):7013-7027. PubMed ID: 34121323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histone methyltransferase PRMT6 plays an oncogenic role of in prostate cancer.
    Almeida-Rios D; Graça I; Vieira FQ; Ramalho-Carvalho J; Pereira-Silva E; Martins AT; Oliveira J; Gonçalves CS; Costa BM; Henrique R; Jerónimo C
    Oncotarget; 2016 Aug; 7(33):53018-53028. PubMed ID: 27323813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determining the Clinical Value and Critical Pathway of GTPBP4 in Lung Adenocarcinoma Using a Bioinformatics Strategy: A Study Based on Datasets from The Cancer Genome Atlas.
    Zhang Z; Wang J; Mao J; Li F; Chen W; Wang W
    Biomed Res Int; 2020; 2020():5171242. PubMed ID: 33134380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SMYD2 promotes tumorigenesis and metastasis of lung adenocarcinoma through RPS7.
    Wu L; Kou F; Ji Z; Li B; Zhang B; Guo Y; Yang L
    Cell Death Dis; 2021 May; 12(5):439. PubMed ID: 33935284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of KIF18A promotes cell proliferation, inhibits apoptosis, and independently predicts unfavorable prognosis in lung adenocarcinoma.
    Zhong Y; Jiang L; Lin H; Li X; Long X; Zhou Y; Li B; Li Z
    IUBMB Life; 2019 Jul; 71(7):942-955. PubMed ID: 30817091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual-specificity tyrosine-regulated kinase 2 exerts anti-tumor effects by induction of G1 arrest in lung adenocarcinoma.
    Harada E; Yoshida S; Imaizumi Y; Kawamura A; Ohtsuka T; Yoshida K
    Biochim Biophys Acta Gen Subj; 2024 Jun; 1868(6):130600. PubMed ID: 38508285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rab27b Is a Potential Indicator for Lymph Node Metastasis and Unfavorable Prognosis in Lung Adenocarcinoma.
    Zhang L; Fan W; Xu L; Mao Q; Chen Y; Mao Y; Xu L; Wang J
    Dis Markers; 2018; 2018():7293962. PubMed ID: 30627227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High expression of keratin 6C is associated with poor prognosis and accelerates cancer proliferation and migration by modulating epithelial-mesenchymal transition in lung adenocarcinoma.
    Hu HB; Yang XP; Zhou PX; Yang XA; Yin B
    Genes Genomics; 2020 Feb; 42(2):179-188. PubMed ID: 31768767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel lncRNA, LUADT1, promotes lung adenocarcinoma proliferation via the epigenetic suppression of p27.
    Qiu M; Xu Y; Wang J; Zhang E; Sun M; Zheng Y; Li M; Xia W; Feng D; Yin R; Xu L
    Cell Death Dis; 2015 Aug; 6(8):e1858. PubMed ID: 26291312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein arginine methyltransferase 6-dependent gene expression and splicing: association with breast cancer outcomes.
    Dowhan DH; Harrison MJ; Eriksson NA; Bailey P; Pearen MA; Fuller PJ; Funder JW; Simpson ER; Leedman PJ; Tilley WD; Brown MA; Clarke CL; Muscat GE
    Endocr Relat Cancer; 2012 Aug; 19(4):509-26. PubMed ID: 22673335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell cycle regulation by the PRMT6 arginine methyltransferase through repression of cyclin-dependent kinase inhibitors.
    Kleinschmidt MA; de Graaf P; van Teeffelen HA; Timmers HT
    PLoS One; 2012; 7(8):e41446. PubMed ID: 22916108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.